Shares of several companies in the broader cannabis and consumer discretionary sector, including Tilray Inc TLRY, are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement.
The Federal Reserve raised its target fed funds rate by 0.5% on Wednesday to a new range of between 0.75% and 1.0%, its first rate hike of at least half a percentage point in more than 20 years. The Fed also said it will begin reducing the size of its balance sheet starting on June 1… Read More
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.
The stock closed Thursday down 7.7% at $4.89. According to data from Benzinga Pro, Tilray has a 52-week high of $23.04 and a 52-week low of $4.78.
BENZINGA CANNABIS CONFERENCE
Meet the biggest cannabis industry players and make deals that will push the industry forward.
Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.
Join us September 13-14, 2022 at The Palmer House in Chicago, IL.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.